Seeking Alpha

Cubist Pharmaceuticals, Inc. (CBST)

()

News & PR
Market Currents

Buzz
Twitter: CBST

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

This Week's Biotech Deal-Making and Financing

Dec 20 • The Burrill Report • 1 Comment
Biotech Stocks for a Possible Year-End Rally

Nov 18 • R. Scott Raynovich • 2 Comments
What We Like About Cubist Pharma

Nov 5 • Andrew Horowitz • 1 Comment
Biotech: Q3 Market Update

Oct 16 • R. Scott Raynovich • 1 Comment
Thursday Options Update: BRCD, WYN, CAR, TGT, CBST & KMB

Oct 8 • Andrew Wilkinson • 1 Comment
Friday Options Recap

Sep 4 • Frederic Ruffy • 2 Comments
Thursday Options Recap

Sep 3 • Frederic Ruffy • Comment!
Cubist Pharma: Bulls Are Stampeding In

Aug 5 • optionMONSTER • 1 Comment
Wednesday Options Update: CBST, EFA, IYR, WFMI, PG, FXI, UNG and DVA

Aug 5 • Andrew Wilkinson • 1 Comment
36 Winners in 2008 That Are Stragglers in 2009

Jul 27 • Alan Brochstein • Comment!
FDA Calendar Updates: King Pharma, Pain Therapeutics

Jul 8 • Mike Havrilla • 6 Comments
Buys for a Down Day

Jun 23 • Mark Riddix • 3 Comments
Does More Cash and Less Debt Equal Stock Market Gains?

Apr 23 • Trade Radar Operator • 1 Comment
Friday's Options Recap

Apr 3 • Frederic Ruffy • 2 Comments
Options Trader Friday Update: GE, TGT, XLI, CBST, HAL, DELL, XRT, CAL, JAVA

Apr 3 • Andrew Wilkinson • 2 Comments
Teva Shows Cubist That Saving Lives Isn't Good Enough

Feb 12 • Investment U • 4 Comments
Cubist and Alnylam, An Odd Partnership

Jan 11 • Eben Tessari • Comment!
2009: Positive Outlook for Biotech

Jan 8 • Michael Becker • 1 Comment
2008 Stock Market: 51 Rays of Light

Jan 7 • Market Folly • 1 Comment
Eight Areas to Consider About This Market

Nov 23, 2008 • Michael Cintolo • 7 Comments
Underdog Smallcaps: Potential Short Squeezes

Sep 14, 2008 • J Clinton Hill • 6 Comments
Cash Is King: Accrual Earnings Stock Screen

Aug 19, 2008 • Mark Barath • 6 Comments
Pfizer Should Buy Amgen or Wyeth - Credit Suisse

Mar 9, 2008 • Mike Huckman • 1 Comment
The Long Case for Targanta Therapeutics

Jan 31, 2008 • Andrew Waight • 2 Comments
Cubist Pharmaceuticals: Betting On Biotech

Jan 8, 2008 • Michael Michaud • Comment!
Staph Buzz Spotlights Cubist, Pfizer, Encysive

Oct 25, 2007 • Brett Scott • 7 Comments
Biotech Day in Review: Eisai Buys Morphotek for $325 Million

Mar 23, 2007 • Centient Biotech Investor • Comment!
Cubist Pharma Focuses On Abandoned Antibiotic Market

Feb 20, 2007 • Faisal Laljee • Comment!

Cubist Pharmaceuticals, Inc. (CBST)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers